On the public citation graph

Ebola virus-like particles protect from lethal Ebola virus infection

0 signed · 289 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/(sici)1097-0215(19980209)75:4<529::aid-ijc7>3.0.co;2-vopenalex-snapshot

Immunoglobulin-A and -G responses against virus-like particles (VLP) of human papillomavirus type 16 in women with cervical cancer and cervical intra-epithelial lesions

inferredcites →https://doi.org/10.1002/eji.1830261109openalex-snapshot

Dendritic cells process exogenous viral proteins and virus‐like particles for class I presentation to CD8+ cytotoxic T lymphocytes

inferredcites →https://doi.org/10.1006/meth.1999.0843openalex-snapshot

Parvovirus-Like Particles as Vaccine Vectors

inferredcites →https://doi.org/10.1006/viro.1997.8883openalex-snapshot

Antigenicity and Vaccine Potential of Marburg Virus Glycoprotein Expressed by Baculovirus Recombinants

inferredcites →https://doi.org/10.1006/viro.1998.9176openalex-snapshot

DNA Vaccines Expressing either the GP or NP Genes of Ebola Virus Protect Mice from Lethal Challenge

inferredcites →https://doi.org/10.1006/viro.1998.9367openalex-snapshot

Marburg Virus Vaccines Based upon Alphavirus Replicons Protect Guinea Pigs and Nonhuman Primates

inferredcites →https://doi.org/10.1006/viro.2001.1012openalex-snapshot

Vaccine Potential of Ebola Virus VP24, VP30, VP35, and VP40 Proteins

inferredcites →https://doi.org/10.1007/978-3-7091-7482-1_11openalex-snapshot

Experimental infection of cynomolgus macaques with Ebola-Reston filoviruses from the 1989–1990 U.S. epizootic

inferredcites →https://doi.org/10.1007/pl00000821openalex-snapshot

Ebola virus: the search for vaccines and treatments

inferredcites →https://doi.org/10.1016/s0042-6822(03)00233-2openalex-snapshot

Protection from lethal infection is determined by innate immune responses in a mouse model of Ebola virus infection

inferredcites →https://doi.org/10.1016/s0065-3527(08)60733-2openalex-snapshot

Marburg and Ebola Viruses

inferredcites →https://doi.org/10.1016/s0140-6736(00)02405-3openalex-snapshot

Human asymptomatic Ebola infection and strong inflammatory response

inferredcites →https://doi.org/10.1016/s0140-6736(95)92841-3openalex-snapshot

Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory

inferredcites →https://doi.org/10.1016/s0165-2478(98)00157-6openalex-snapshot

HIV-1 vaccine-induced immune responses which correlate with protection from SHIV infection: compiled preclinical efficacy data from trials with ten different HIV-1 vaccine candidates

inferredcites →https://doi.org/10.1016/s0165-2478(99)00169-8openalex-snapshot

Immune and pathophysiological processes in baboons experimentally infected with Ebola virus adapted to guinea pigs

inferredcites →https://doi.org/10.1016/s0166-3542(00)00136-4openalex-snapshot

High efficient production of Pr55gag virus-like particles expressing multiple HIV-1 epitopes, including a gp120 protein derived from an Ugandan HIV-1 isolate of subtype A

inferredcites →https://doi.org/10.1016/s0168-1702(02)00354-4openalex-snapshot

Vaccine for AIDS and Ebola virus infection

inferredcites →https://doi.org/10.1016/s0264-410x(00)00113-4openalex-snapshot

Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus

inferredcites →https://doi.org/10.1016/s0264-410x(01)00093-7openalex-snapshot

Antibody, cytokine and cytotoxic T lymphocyte responses in chimpanzees immunized with human papillomavirus virus-like particles

inferredcites →https://doi.org/10.1016/s0264-410x(01)00353-xopenalex-snapshot

Marburg virus vaccines: comparing classical and new approaches

inferredcites →https://doi.org/10.1038/35046108openalex-snapshot

Development of a preventive vaccine for Ebola virus infection in primates

inferredcites →https://doi.org/10.1038/nature01876openalex-snapshot

Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates

inferredcites →https://doi.org/10.1046/j.1365-2249.2001.01517.xopenalex-snapshot

Early immune responses accompanying human asymptomatic Ebola infections

inferredcites →https://doi.org/10.1046/j.1365-2249.2002.01800.xopenalex-snapshot

Inflammatory responses in Ebola virus-infected patients

inferredcites →https://doi.org/10.1053/jcpa.2001.0502openalex-snapshot

Pathogenesis of Experimental Ebola Zaire Virus Infection in BALB/c Mice

inferredcites →https://doi.org/10.1073/pnas.220398297openalex-snapshot

The Ebola virus VP35 protein functions as a type I IFN antagonist

inferredcites →https://doi.org/10.1084/jem.176.6.1693openalex-snapshot

Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.

inferredcites →https://doi.org/10.1084/jem.189.5.821openalex-snapshot

Maturation, Activation, and Protection of Dendritic Cells Induced by Double-stranded RNA

inferredcites →https://doi.org/10.1084/jem.20011500openalex-snapshot

Lipid Raft Microdomains

inferredcites →https://doi.org/10.1084/jem.20011930openalex-snapshot

CD8α2 CD11b+ Dendritic Cells Present Exogenous Virus-like Particles to CD8+ T Cells and Subsequently Express CD8α and CD205 Molecules

inferredcites →https://doi.org/10.1084/jem.20012040openalex-snapshot

Dendritic and Natural Killer Cells Cooperate in the Control/Switch of Innate Immunity

inferredcites →https://doi.org/10.1086/379199openalex-snapshot

Ebola and Marburg Viruses Replicate in Monocyte‐Derived Dendritic Cells without Inducing the Production of Cytokines and Full Maturation

inferredcites →https://doi.org/10.1086/514283openalex-snapshot

Markedly Elevated Levels of Interferon (IFN)‐σ, IFN‐α, Interleukin (IL)‐2, IL‐10, and Tumor Necrosis Factor‐α Associated with Fatal Ebola Virus Infection

inferredcites →https://doi.org/10.1086/514310openalex-snapshot

Evaluation of Immune Globulin and Recombinant Interferon‐α2b for Treatment of Experimental Ebola Virus Infections

inferredcites →https://doi.org/10.1086/515386openalex-snapshot

A Mouse Model for Evaluation of Prophylaxis and Therapy of Ebola Hemorrhagic Fever

inferredcites →https://doi.org/10.1093/clinids/11.supplement_4.s730openalex-snapshot

Epidemiology of Hemorrhagic Fever Viruses

inferredcites →https://doi.org/10.1093/infdis/174.supplement_1.s88openalex-snapshot

Virus-Like Particles As A Rotavirus Subunit Vaccine

inferredcites →https://doi.org/10.1093/intimm/13.5.633openalex-snapshot

Physical interaction of human papillomavirus virus-like particles with immune cells

inferredcites →https://doi.org/10.1111/j.1574-6968.1996.tb08371.xopenalex-snapshot

Production of human papillomavirus type 45 virus-like particles in insect cells using a recombinant baculovirus

inferredcites →https://doi.org/10.1126/science.287.5458.1664openalex-snapshot

Epitopes Involved in Antibody-Mediated Protection from Ebola Virus

inferredcites →https://doi.org/10.1128/jcm.13.4.791-793.1981openalex-snapshot

Plaque Assay for Ebola Virus

inferredcites →https://doi.org/10.1128/jvi.75.10.4649-4654.2001openalex-snapshot

Passive Transfer of Antibodies Protects Immunocompetent and Immunodeficient Mice against Lethal Ebola Virus Infection without Complete Inhibition of Viral Replication

inferredcites →https://doi.org/10.1128/jvi.75.22.11025-11033.2001openalex-snapshot

Infection and Activation of Monocytes by Marburg and Ebola Viruses

inferredcites →https://doi.org/10.1128/jvi.75.6.2660-2664.2001openalex-snapshot

Protection from Ebola Virus Mediated by Cytotoxic T Lymphocytes Specific for the Viral Nucleoprotein

inferredcites →https://doi.org/10.1128/jvi.76.18.9176-9185.2002openalex-snapshot

Induction of Immune Responses in Mice and Monkeys to Ebola Virus after Immunization with Liposome-Encapsulated Irradiated Ebola Virus: Protection in Mice Requires CD4 + T Cells

inferredcites →https://doi.org/10.1128/jvi.77.1.799-803.2003openalex-snapshot

Overcoming Immunity to a Viral Vaccine by DNA Priming before Vector Boosting

inferredcites →https://doi.org/10.1146/annurev.immunol.20.100301.064828openalex-snapshot

Antigen Presentation and T Cell Stimulation by Dendritic Cells

inferredcites →https://doi.org/10.17226/12910openalex-snapshot

Guide for the Care and Use of Laboratory Animals

inferredcites →https://doi.org/10.2174/1568005014605973openalex-snapshot

Bacterial Carriers and Virus-Like-Particles as Antigen Delivery Devices: Role of Dendritic Cells in Antigen Presentation

inferredcites →https://doi.org/10.3201/eid0805.010284openalex-snapshot

Evaluation in Nonhuman Primates of Vaccines against Ebola Virus

inferredcites →https://doi.org/10.4049/jimmunol.166.9.5346openalex-snapshot

Papillomavirus-Like Particles Induce Acute Activation of Dendritic Cells

inferredcites →https://doi.org/10.4049/jimmunol.170.6.2797openalex-snapshot

Cutting Edge: Impairment of Dendritic Cells and Adaptive Immunity by Ebola and Lassa Viruses

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.5239526openalex-extracted

Oral Immunization with Filoviral-Like Particles Elicits Ebola Virus-Specific Humoral and Cellular Immune Responses in Mice

inferred← citeshttps://doi.org/10.1002/bit.22299openalex-snapshot

A DNA replicon system for rapid high‐level production of virus‐like particles in plants

inferred← citeshttps://doi.org/10.1002/eji.201444594openalex-snapshot

Natural killer and dendritic cells collaborate in the immune response induced by the vaccine against uterine cervical cancer

inferred← citeshttps://doi.org/10.1002/jps.22724openalex-snapshot

Biophysical Characterization and Conformational Stability of Ebola and Marburg Virus-Like Particles

inferred← citeshttps://doi.org/10.1002/wnan.119openalex-snapshot

Viral nanoparticles and virus‐like particles: platforms for contemporary vaccine design

inferred← citeshttps://doi.org/10.1002/wnan.1403openalex-snapshot

Particulate delivery systems for vaccination against bioterrorism agents and emerging infectious pathogens

inferred← citeshttps://doi.org/10.1007/7355_2015_5003openalex-snapshot

Clinical Management of Ebola Virus Disease: Current and Future Approaches

inferred← citeshttps://doi.org/10.1007/82_2017_15openalex-snapshot

Inside the Cell: Assembly of Filoviruses

inferred← citeshttps://doi.org/10.1007/978-1-4939-7116-9_22openalex-snapshot

Assessing Antiviral Countermeasures Using Mouse Models of Ebolavirus Infection

inferred← citeshttps://doi.org/10.1007/978-1-4939-7116-9_8openalex-snapshot

Modeling Ebolavirus Budding with Virus Like Particles

inferred← citeshttps://doi.org/10.1007/978-3-540-70962-6_16openalex-snapshot

Pre-spillover Prevention of Emerging Zoonotic Diseases: What Are the Targets and What Are the Tools?

inferred← citeshttps://doi.org/10.1007/s00018-007-7406-2openalex-snapshot

Filoviruses: Interactions with the host cell

inferred← citeshttps://doi.org/10.1007/s00109-023-02309-4openalex-snapshot

Ebola virus–like particles reprogram cellular metabolism

inferred← citeshttps://doi.org/10.1007/s00253-015-7000-8openalex-snapshot

The application of virus-like particles as vaccines and biological vehicles

inferred← citeshttps://doi.org/10.1007/s00425-017-2689-5openalex-snapshot

Expression of the VP40 antigen from the Zaire ebolavirus in tobacco plants

inferred← citeshttps://doi.org/10.1007/s00705-010-0734-9openalex-snapshot

Nucleocapsid-like particles of dengue-2 virus enhance the immune response against a recombinant protein of dengue-4 virus

inferred← citeshttps://doi.org/10.1007/s00705-012-1565-7openalex-snapshot

Characterization and immunogenicity of norovirus capsid-derived virus-like particles purified by anion exchange chromatography

inferred← citeshttps://doi.org/10.1007/s11262-007-0108-xopenalex-snapshot

Hydrophilicity dependent budding and secretion of chimeric HIV Gag-V3 virus-like particles

inferred← citeshttps://doi.org/10.1007/s11262-017-1455-xopenalex-snapshot

Ebola and Marburg virus vaccines

inferred← citeshttps://doi.org/10.1007/s12033-012-9598-4openalex-snapshot

Construction and Characterization of Virus-Like Particles: A Review

inferred← citeshttps://doi.org/10.1007/s12250-013-3306-9openalex-snapshot

Characterization of a putative filovirus vaccine: Virus-like particles

inferred← citeshttps://doi.org/10.1007/s12250-016-3756-yopenalex-snapshot

Virus like particle-based vaccines against emerging infectious disease viruses

inferred← citeshttps://doi.org/10.1007/s12250-016-3845-yopenalex-snapshot

A new strategy for full-length Ebola virus glycoprotein expression in E.coli

inferred← citeshttps://doi.org/10.1007/s13337-013-0130-7openalex-snapshot

Immune Regulation and Evasion of Mammalian Host Cell Immunity During Viral Infection

inferred← citeshttps://doi.org/10.1016/b978-0-12-369408-9.00020-2openalex-snapshot

Ebola and Marburg

inferred← citeshttps://doi.org/10.1016/b978-0-12-374537-8.00028-6openalex-snapshot

Detection of Highly Pathogenic Viral Agents

inferred← citeshttps://doi.org/10.1016/b978-0-12-416020-0.00006-1openalex-snapshot

Engineered Biological Entities for Drug Delivery and Gene Therapy

inferred← citeshttps://doi.org/10.1016/b978-0-323-03253-7.50129-1openalex-snapshot

Viral Hemorrhagic Fever Attack—Filo Viruses

inferred← citeshttps://doi.org/10.1016/b978-0-323-28665-7.00144-8openalex-snapshot

Viral Hemorrhagic Fever Attack

inferred← citeshttps://doi.org/10.1016/b978-0-443-33639-3.00024-6openalex-snapshot

Virus-like particle (VLP)-based nanocarriers for drug delivery

inferred← citeshttps://doi.org/10.1016/b978-0-7020-3935-5.00073-2openalex-snapshot

Filovirus Infections

inferred← citeshttps://doi.org/10.1016/j.addr.2005.01.010openalex-snapshot

Particulate delivery systems for biodefense subunit vaccines

inferred← citeshttps://doi.org/10.1016/j.antiviral.2007.10.002openalex-snapshot

Animal models of highly pathogenic RNA viral infections: Hemorrhagic fever viruses

inferred← citeshttps://doi.org/10.1016/j.antiviral.2009.09.005openalex-snapshot

Immunization by influenza virus-like particles protects aged mice against lethal influenza virus challenge

inferred← citeshttps://doi.org/10.1016/j.antiviral.2012.01.011openalex-snapshot

The role of antigen-presenting cells in filoviral hemorrhagic fever: Gaps in current knowledge

inferred← citeshttps://doi.org/10.1016/j.antiviral.2015.11.012openalex-snapshot

Quantitative serology assays for determination of antibody responses to Ebola virus glycoprotein and matrix protein in nonhuman primates and humans

inferred← citeshttps://doi.org/10.1016/j.antiviral.2017.11.016openalex-snapshot

Retro-2 and its dihydroquinazolinone derivatives inhibit filovirus infection

inferred← citeshttps://doi.org/10.1016/j.antiviral.2023.105551openalex-snapshot

Characterization of an air-liquid interface primary human vaginal epithelium to study Ebola virus infection and testing of antivirals

inferred← citeshttps://doi.org/10.1016/j.atc.2004.04.004openalex-snapshot

Bioterrorism and children

inferred← citeshttps://doi.org/10.1016/j.bbrc.2016.09.052openalex-snapshot

Human transbodies to VP40 inhibit cellular egress of Ebola virus-like particles

inferred← citeshttps://doi.org/10.1016/j.bbrc.2026.153346openalex-snapshot

Bioengineered chimeric VLPs targeting chikungunya virus and SARS-CoV-2 show high immunogenicity in mice

inferred← citeshttps://doi.org/10.1016/j.ccc.2005.06.007openalex-snapshot

Hemorrhagic Fever Viruses

inferred← citeshttps://doi.org/10.1016/j.cll.2006.05.001openalex-snapshot

Viral Hemorrhagic Fevers

inferred← citeshttps://doi.org/10.1016/j.copbio.2004.10.002openalex-snapshot

Virus-like particles as vaccines and vessels for the delivery of small molecules

inferred← citeshttps://doi.org/10.1016/j.coviro.2014.02.009openalex-snapshot

Subviral particle as vaccine and vaccine platform

inferred← citeshttps://doi.org/10.1016/j.coviro.2021.10.007openalex-snapshot

Therapeutic vaccination strategies against EBOV by rVSV-EBOV-GP: the role of innate immunity

inferred← citeshttps://doi.org/10.1016/j.ebiom.2015.11.041openalex-snapshot

Adjuvant-enhanced CD4 T Cell Responses are Critical to Durable Vaccine Immunity

inferred← citeshttps://doi.org/10.1016/j.ejps.2023.106460openalex-snapshot

Viral protein nanoparticles (Part 1): Pharmaceutical characteristics

inferred← citeshttps://doi.org/10.1016/j.gene.2026.150208openalex-snapshot

Virus-like particles: Bridging immunization and precision drug delivery

inferred← citeshttps://doi.org/10.1016/j.heliyon.2024.e34927openalex-snapshot

Viral vector- and virus-like particle-based vaccines against infectious diseases: A minireview

inferred← citeshttps://doi.org/10.1016/j.jcv.2015.01.014openalex-snapshot

Ebola and Marburg haemorrhagic fever

inferred← citeshttps://doi.org/10.1016/j.jlr.2024.100663openalex-snapshot

A fatty acid-ordered plasma membrane environment is critical for Ebola virus matrix protein assembly and budding

inferred← citeshttps://doi.org/10.1016/j.jobb.2023.05.001openalex-snapshot

The potential epidemic threat of Ebola virus and the development of a preventive vaccine

inferred← citeshttps://doi.org/10.1016/j.jviromet.2005.02.015openalex-snapshot

Analysis of Ebola virus and VLP release using an immunocapture assay

inferred← citeshttps://doi.org/10.1016/j.jviromet.2007.02.004openalex-snapshot

Production and characterization of monoclonal antibodies against different epitopes of Ebola virus antigens

inferred← citeshttps://doi.org/10.1016/j.jviromet.2007.12.004openalex-snapshot

The creation of stable cell lines expressing Ebola virus glycoproteins and the matrix protein VP40 and generating Ebola virus-like particles utilizing an ecdysone inducible mammalian expression system

inferred← citeshttps://doi.org/10.1016/j.jviromet.2010.07.015openalex-snapshot

Novel suspension cell-based vaccine production systems for Rift Valley fever virus-like particles

inferred← citeshttps://doi.org/10.1016/j.mam.2007.09.005openalex-snapshot

Ebolavirus and Marburgvirus: Insight the Filoviridae family

inferred← citeshttps://doi.org/10.1016/j.micinf.2014.12.004openalex-snapshot

Development of vaccines for prevention of Ebola virus infection

inferred← citeshttps://doi.org/10.1016/j.omtn.2025.102722openalex-snapshot

Infection-sensing minigenome as a novel therapeutic approach against Ebola virus

inferred← citeshttps://doi.org/10.1016/j.rvsc.2011.10.018openalex-snapshot

Virus-like particles: potential veterinary vaccine immunogens

inferred← citeshttps://doi.org/10.1016/j.sbi.2009.05.004openalex-snapshot

Neutralizing ebolavirus: structural insights into the envelope glycoprotein and antibodies targeted against it

inferred← citeshttps://doi.org/10.1016/j.sciaf.2021.e00862openalex-snapshot

Ebola Virus Disease, Diagnostics and Therapeutics: Where is the Consensus in Over Three Decades of Clinical Research?

inferred← citeshttps://doi.org/10.1016/j.vaccine.2004.01.063openalex-snapshot

Marburg virus-like particles protect guinea pigs from lethal Marburg virus infection

inferred← citeshttps://doi.org/10.1016/j.vaccine.2004.11.070openalex-snapshot

Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections

inferred← citeshttps://doi.org/10.1016/j.vaccine.2005.11.046openalex-snapshot

De novo syntheses of Marburg virus antigens from adenovirus vectors induce potent humoral and cellular immune responses

inferred← citeshttps://doi.org/10.1016/j.vaccine.2006.11.037openalex-snapshot

Status and challenges of filovirus vaccines

inferred← citeshttps://doi.org/10.1016/j.vaccine.2010.10.037openalex-snapshot

A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults

inferred← citeshttps://doi.org/10.1016/j.vaccine.2011.01.113openalex-snapshot

Ebola virus glycoprotein Fc fusion protein confers protection against lethal challenge in vaccinated mice

inferred← citeshttps://doi.org/10.1016/j.vaccine.2012.07.073openalex-snapshot

Further characterization of the immune response in mice to inactivated and live rabies vaccines expressing Ebola virus glycoprotein

inferred← citeshttps://doi.org/10.1016/j.vaccine.2012.10.083openalex-snapshot

Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development

inferred← citeshttps://doi.org/10.1016/j.vaccine.2017.01.068openalex-snapshot

Recombinant proteins of Zaire ebolavirus induce potent humoral and cellular immune responses and protect against live virus infection in mice

inferred← citeshttps://doi.org/10.1016/j.vaccine.2018.09.003openalex-snapshot

Intranasal vaccination with ebola virus GP amino acids 258–601 protects mice against lethal challenge

inferred← citeshttps://doi.org/10.1016/j.vaccine.2019.05.026openalex-snapshot

Glucopyranosyl lipid adjuvant enhances immune response to Ebola virus-like particle vaccine in mice

inferred← citeshttps://doi.org/10.1016/j.vaccine.2020.04.034openalex-snapshot

An effective CTL peptide vaccine for Ebola Zaire Based on Survivors’ CD8+ targeting of a particular nucleocapsid protein epitope with potential implications for COVID-19 vaccine design

inferred← citeshttps://doi.org/10.1016/j.vaccine.2024.03.034openalex-snapshot

CHO cells for virus-like particle and subunit vaccine manufacturing

inferred← citeshttps://doi.org/10.1016/j.vaccine.2026.128764openalex-snapshot

Oral immunization with virus-like particles elicits Ebola virus-specific humoral and cellular immune responses in mice

inferred← citeshttps://doi.org/10.1016/j.vacun.2015.07.002openalex-snapshot

Situación actual de las vacunas frente al virus del Ébola

inferred← citeshttps://doi.org/10.1016/j.virol.2004.05.025openalex-snapshot

Ebola and Marburg virus-like particles activate human myeloid dendritic cells

inferred← citeshttps://doi.org/10.1016/j.virol.2005.09.018openalex-snapshot

Filovirus assembly and budding

inferred← citeshttps://doi.org/10.1016/j.virol.2006.03.021openalex-snapshot

Ebola virus-like particles produced in insect cells exhibit dendritic cell stimulating activity and induce neutralizing antibodies

inferred← citeshttps://doi.org/10.1016/j.virol.2006.05.033openalex-snapshot

Complex adenovirus-vectored vaccine protects guinea pigs from three strains of Marburg virus challenges

inferred← citeshttps://doi.org/10.1016/j.virol.2006.09.042openalex-snapshot

Computational prediction and identification of HLA-A2.1-specific Ebola virus CTL epitopes

inferred← citeshttps://doi.org/10.1016/j.virol.2007.03.020openalex-snapshot

Ebola virus-like particle-induced activation of NF-κB and Erk signaling in human dendritic cells requires the glycoprotein mucin domain

inferred← citeshttps://doi.org/10.1016/j.virol.2008.09.020openalex-snapshot

Protection against lethal challenge by Ebola virus-like particles produced in insect cells

inferred← citeshttps://doi.org/10.1016/j.virol.2009.11.001openalex-snapshot

A replication-incompetent Rift Valley fever vaccine: Chimeric virus-like particles protect mice and rats against lethal challenge

inferred← citeshttps://doi.org/10.1016/j.virusres.2004.08.014openalex-snapshot

Filovirus budding

inferred← citeshttps://doi.org/10.1016/j.virusres.2011.09.005openalex-snapshot

Progress in recombinant DNA-derived vaccines for Lassa virus and filoviruses

inferred← citeshttps://doi.org/10.1016/j.ymeth.2006.07.018openalex-snapshot

Virus-like particles: Passport to immune recognition

inferred← citeshttps://doi.org/10.1016/j.ymeth.2026.05.012openalex-snapshot

Virus-Like Particles: From Fundamental Concepts to Cutting-Edge Applications — A Comprehensive Review of Production, Engineering, and Clinical Translation

inferred← citeshttps://doi.org/10.1016/s0889-8537(04)00029-xopenalex-snapshot

Bioterrorism and childrenUnique concerns with infection control and vaccination

inferred← citeshttps://doi.org/10.1038/emi.2017.31openalex-snapshot

T-cell-dependent mechanisms promote Ebola VLP-induced antibody responses, but are dispensable for vaccine-mediated protection

inferred← citeshttps://doi.org/10.1038/nrd1694openalex-snapshot

The evolving field of biodefence: therapeutic developments and diagnostics

inferred← citeshttps://doi.org/10.1038/s41392-023-01408-5openalex-snapshot

Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases

inferred← citeshttps://doi.org/10.1038/s41426-018-0102-5openalex-snapshot

An adenovirus serotype 2-vectored ebolavirus vaccine generates robust antibody and cell-mediated immune responses in mice and rhesus macaques

inferred← citeshttps://doi.org/10.1038/s41467-021-22867-wopenalex-snapshot

Single-component multilayered self-assembling nanoparticles presenting rationally designed glycoprotein trimers as Ebola virus vaccines

inferred← citeshttps://doi.org/10.1038/s41541-020-00219-xopenalex-snapshot

Adjuvant formulated virus-like particles expressing native-like forms of the Lassa virus envelope surface glycoprotein are immunogenic and induce antibodies with broadly neutralizing activity

inferred← citeshttps://doi.org/10.1038/s41541-023-00615-zopenalex-snapshot

Effects of adjuvants in a rabies-vectored Ebola virus vaccine on protection from surrogate challenge

inferred← citeshttps://doi.org/10.1038/s41598-018-23357-8openalex-snapshot

A Critical Domain of Ebolavirus Envelope Glycoprotein Determines Glycoform and Infectivity

inferred← citeshttps://doi.org/10.1038/s41598-026-44944-0openalex-snapshot

Oral immunization with filovirus-like particles partially protects IFNAR−/− mice against lethal ebola virus challenge

inferred← citeshttps://doi.org/10.1038/srep45552openalex-snapshot

Antibody-dependent-cellular-cytotoxicity-inducing antibodies significantly affect the post-exposure treatment of Ebola virus infection

inferred← citeshttps://doi.org/10.1039/9781788016858-00091openalex-snapshot

Antiviral Strategies for Ebola Virus and Other Filoviruses: Antibodies

inferred← citeshttps://doi.org/10.1051/medsci/2006224405openalex-snapshot

Ebola et Marburg : les homes contre-attaquent

inferred← citeshttps://doi.org/10.1080/01652176.2017.1309474openalex-snapshot

Ebola virus – epidemiology, diagnosis, and control: threat to humans, lessons learnt, and preparedness plans – an update on its 40 year's journey

inferred← citeshttps://doi.org/10.1080/14760584.2016.1187566openalex-snapshot

Ebola virus disease candidate vaccines under evaluation in clinical trials

inferred← citeshttps://doi.org/10.1080/14764170500223456openalex-snapshot

Ebola hemorrhagic fever: a paradigm of multiorgan dysfunction

inferred← citeshttps://doi.org/10.1080/21645515.2016.1225637openalex-snapshot

Ebola vaccines in clinical trial: The promising candidates

inferred← citeshttps://doi.org/10.1080/21645515.2019.1651140openalex-snapshot

Vaccines against Ebola virus and Marburg virus: recent advances and promising candidates

inferred← citeshttps://doi.org/10.1080/22221751.2026.2732697openalex-snapshot

Differential glycosylation in the envelope glycoprotein enhances DC-SIGN-mediated cell entry of the West African Ebolavirus Makona

inferred← citeshttps://doi.org/10.1084/jem.20032141openalex-snapshot

Role of Natural Killer Cells in Innate Protection against Lethal Ebola Virus Infection

inferred← citeshttps://doi.org/10.1086/520581openalex-snapshot

Epitopes Required for Antibody‐Dependent Enhancement of Ebola Virus Infection

inferred← citeshttps://doi.org/10.1086/520583openalex-snapshot

Ebola Virus‐Like Particle–Based Vaccine Protects Nonhuman Primates against Lethal Ebola Virus Challenge

inferred← citeshttps://doi.org/10.1086/520605openalex-snapshot

Ebola Virus Inactivation with Preservation of Antigenic and Structural Integrity by a Photoinducible Alkylating Agent

inferred← citeshttps://doi.org/10.1086/520612openalex-snapshot

Filovirus‐Like Particles Produced in Insect Cells: Immunogenicity and Protection in Rodents

inferred← citeshttps://doi.org/10.1089/jir.2013.0035openalex-snapshot

Ebola Virus-Like Particles Stimulate Type I Interferons and Proinflammatory Cytokine Expression Through the Toll-Like Receptor and Interferon Signaling Pathways

inferred← citeshttps://doi.org/10.1089/vim.2005.18.244openalex-snapshot

Virus-Like Particle (VLP) Vaccine Conferred Complete Protection against a Lethal Influenza Virus Challenge

inferred← citeshttps://doi.org/10.1089/vim.2005.18.365openalex-snapshot

Virus-Like Particle Vaccine Conferred Complete Protection Against a Lethal Influenza Virus Challenge

inferred← citeshttps://doi.org/10.1089/vim.2014.0071openalex-snapshot

Cross-Protection Conferred by Filovirus Virus-Like Particles Containing Trimeric Hybrid Glycoprotein

inferred← citeshttps://doi.org/10.1093/infdis/jir295openalex-snapshot

Impact of Ebola Mucin-Like Domain on Antiglycoprotein Antibody Responses Induced by Ebola Virus-Like Particles

inferred← citeshttps://doi.org/10.1093/infdis/jir321openalex-snapshot

Genomic RNA Editing and Its Impact on Ebola Virus Adaptation During Serial Passages in Cell Culture and Infection of Guinea Pigs

inferred← citeshttps://doi.org/10.1093/infdis/jir332openalex-snapshot

Impact of Systemic or Mucosal Immunity to Adenovirus on Ad-Based Ebola Virus Vaccine Efficacy in Guinea Pigs

inferred← citeshttps://doi.org/10.1093/infdis/jir346openalex-snapshot

Advances in Virus-Like Particle Vaccines for Filoviruses

inferred← citeshttps://doi.org/10.1093/infdis/jir348openalex-snapshot

Vesicular Stomatitis Virus–Based Ebola Vaccines With Improved Cross-Protective Efficacy

inferred← citeshttps://doi.org/10.1093/infdis/jiv186openalex-snapshot

Characterization of Immune Responses Induced by Ebola Virus Glycoprotein (GP) and Truncated GP Isoform DNA Vaccines and Protection Against Lethal Ebola Virus Challenge in Mice

inferred← citeshttps://doi.org/10.1093/infdis/jiv251openalex-snapshot

Preclinical Development of Inactivated Rabies Virus–Based Polyvalent Vaccine Against Rabies and Filoviruses

inferred← citeshttps://doi.org/10.1093/infdis/jiv316openalex-snapshot

Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus

inferred← citeshttps://doi.org/10.1093/infdis/jiw231openalex-snapshot

An Inactivated Rabies Virus–Based Ebola Vaccine, FILORAB1, Adjuvanted With Glucopyranosyl Lipid A in Stable Emulsion Confers Complete Protection in Nonhuman Primate Challenge Models

inferred← citeshttps://doi.org/10.1093/infdis/jiy316openalex-snapshot

Role of Antibodies in Protection Against Ebola Virus in Nonhuman Primates Immunized With Three Vaccine Platforms

inferred← citeshttps://doi.org/10.1093/infdis/jiy329openalex-snapshot

Efficacy of Ebola Glycoprotein-Specific Equine Polyclonal Antibody Product Against Lethal Ebola Virus Infection in Guinea Pigs

inferred← citeshttps://doi.org/10.1097/01.cpm.0000156700.53793.c5openalex-snapshot

Update on Ebola Virus and Its Potential as a Bioterrorism Agent

inferred← citeshttps://doi.org/10.1097/01.inf.0000148933.08301.02openalex-snapshot

Six Revolutions in Vaccinology

inferred← citeshttps://doi.org/10.1099/vir.0.017343-0openalex-snapshot

The VP35 protein of Ebola virus impairs dendritic cell maturation induced by virus and lipopolysaccharide

inferred← citeshttps://doi.org/10.1101/2022.08.24.505195openalex-snapshot

Integrity of membrane fluidity and fatty acid environment are necessary for Ebola virus VP40 assembly and release of viral particles

inferred← citeshttps://doi.org/10.1101/2023.01.29.526074openalex-snapshot

Chimeric chikungunya virus-like particles with surface exposed SARS-CoV-2 RBD elicits potent immunogenic responses in mice

inferred← citeshttps://doi.org/10.1101/2024.04.06.588168openalex-snapshot

Single-cell image-based genetic screens systematically identify regulators of Ebola virus subcellular infection dynamics

inferred← citeshttps://doi.org/10.1111/1469-0691.12630openalex-snapshot

Animal models for viral haemorrhagic fever

inferred← citeshttps://doi.org/10.1111/j.0818-9641.2004.01271.xopenalex-snapshot

Vaccines that facilitate antigen entry into dendritic cells

inferred← citeshttps://doi.org/10.1111/j.1365-3024.2009.01099.xopenalex-snapshot

Antigenic protein modifications in Ehrlichia

inferred← citeshttps://doi.org/10.1111/j.1365-3083.2007.01907.xopenalex-snapshot

Bone Marrow Dendritic Cells Internalize Live RF‐81 Bovine Rotavirus and Rotavirus‐like Particles (RF 2/6‐GFP‐VLP and RF 8*2/6/7‐VLP) But are Only Activated by Live Bovine Rotavirus

inferred← citeshttps://doi.org/10.1111/j.1462-5822.2006.00844.xopenalex-snapshot

NKp30-dependent cytolysis of filovirus-infected human dendritic cells

inferred← citeshttps://doi.org/10.1111/j.1751-7915.2011.00293.xopenalex-snapshot

Relevant uses of surface proteins – display on self‐organized biological structures

inferred← citeshttps://doi.org/10.1126/science.aag3267openalex-snapshot

A “Trojan horse” bispecific-antibody strategy for broad protection against ebolaviruses

inferred← citeshttps://doi.org/10.1128/9781555815561.ch15openalex-snapshot

Filoviruses

inferred← citeshttps://doi.org/10.1128/cvi.00431-07openalex-snapshot

Vaccine To Confer to Nonhuman Primates Complete Protection against Multistrain Ebola and Marburg Virus Infections

inferred← citeshttps://doi.org/10.1128/cvi.00467-09openalex-snapshot

Protection of Nonhuman Primates against Two Species of Ebola Virus Infection with a Single Complex Adenovirus Vector

inferred← citeshttps://doi.org/10.1128/jvi.00074-09openalex-snapshot

Replication-Deficient Ebolavirus as a Vaccine Candidate

inferred← citeshttps://doi.org/10.1128/jvi.00343-17openalex-snapshot

Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles

inferred← citeshttps://doi.org/10.1128/jvi.00363-18openalex-snapshot

Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins

inferred← citeshttps://doi.org/10.1128/jvi.00479-17openalex-snapshot

Vesicular Stomatitis Virus Pseudotyped with Ebola Virus Glycoprotein Serves as a Protective, Noninfectious Vaccine against Ebola Virus Challenge in Mice

inferred← citeshttps://doi.org/10.1128/jvi.00558-11openalex-snapshot

Inactivated or Live-Attenuated Bivalent Vaccines That Confer Protection against Rabies and Ebola Viruses

inferred← citeshttps://doi.org/10.1128/jvi.00659-11openalex-snapshot

Functional Genomics Reveals the Induction of Inflammatory Response and Metalloproteinase Gene Expression during Lethal Ebola Virus Infection

inferred← citeshttps://doi.org/10.1128/jvi.01239-16openalex-snapshot

An Ebola Virus-Like Particle-Based Reporter System Enables Evaluation of Antiviral Drugs In Vivo under Non-Biosafety Level 4 Conditions

inferred← citeshttps://doi.org/10.1128/jvi.01462-09openalex-snapshot

Interaction between Ebola Virus Glycoprotein and Host Toll-Like Receptor 4 Leads to Induction of Proinflammatory Cytokines and SOCS1

inferred← citeshttps://doi.org/10.1128/jvi.01884-19openalex-snapshot

A Bivalent, Spherical Virus-Like Particle Vaccine Enhances Breadth of Immune Responses against Pathogenic Ebola Viruses in Rhesus Macaques

inferred← citeshttps://doi.org/10.1128/jvi.02172-15openalex-snapshot

Macaque Monoclonal Antibodies Targeting Novel Conserved Epitopes within Filovirus Glycoprotein

inferred← citeshttps://doi.org/10.1128/jvi.02220-08openalex-snapshot

Severe Acute Respiratory Syndrome Coronavirus Papain-Like Protease Ubiquitin-Like Domain and Catalytic Domain Regulate Antagonism of IRF3 and NF-κB Signaling

inferred← citeshttps://doi.org/10.1128/jvi.02545-05openalex-snapshot

The Signal Peptide of the Ebolavirus Glycoprotein Influences Interaction with the Cellular Lectins DC-SIGN and DC-SIGNR

inferred← citeshttps://doi.org/10.1128/jvi.02864-12openalex-snapshot

Airway Delivery of an Adenovirus-Based Ebola Virus Vaccine Bypasses Existing Immunity to Homologous Adenovirus in Nonhuman Primates

inferred← citeshttps://doi.org/10.1128/jvi.03316-12openalex-snapshot

The Lack of Maturation of Ebola Virus-Infected Dendritic Cells Results from the Cooperative Effect of at Least Two Viral Domains

inferred← citeshttps://doi.org/10.1128/jvi.79.22.14189-14196.2005openalex-snapshot

Protective Cytotoxic T-Cell Responses Induced by Venezuelan Equine Encephalitis Virus Replicons Expressing Ebola Virus Proteins

inferred← citeshttps://doi.org/10.1128/jvi.79.3.1701-1712.2005openalex-snapshot

Contribution of Virus-Like Particles to the Immunogenicity of Human Immunodeficiency Virus Type 1 Gag-Derived Vaccines in Mice

inferred← citeshttps://doi.org/10.1128/jvi.79.4.2413-2419.2005openalex-snapshot

Role of Ebola Virus Secreted Glycoproteins and Virus-Like Particles in Activation of Human Macrophages

inferred← citeshttps://doi.org/10.1128/jvi.79.8.4793-4805.2005openalex-snapshot

Comprehensive Analysis of Ebola Virus GP1 in Viral Entry

inferred← citeshttps://doi.org/10.1128/jvi.80.6.2738-2746.2006openalex-snapshot

Development of a cAdVax-Based Bivalent Ebola Virus Vaccine That Induces Immune Responses against both the Sudan and Zaire Species of Ebola Virus

inferred← citeshttps://doi.org/10.1146/annurev-med-051215-030919openalex-snapshot

Toward an Effective Ebola Virus Vaccine

inferred← citeshttps://doi.org/10.1146/annurev-virology-092818-015708openalex-snapshot

Ebola Virus: Pathogenesis and Countermeasure Development

inferred← citeshttps://doi.org/10.1155/2023/9248581openalex-snapshot

A Bivalent Bacterium-like Particles-Based Vaccine Induced Potent Immune Responses against the Sudan Virus and Ebola Virus in Mice

inferred← citeshttps://doi.org/10.1159/000346773openalex-snapshot

Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures

inferred← citeshttps://doi.org/10.1159/000438531openalex-snapshot

Ebolavirus Vaccines: Progress in the Fight Against Ebola Virus Disease

inferred← citeshttps://doi.org/10.1172/jci.insight.158902openalex-snapshot

Ebola virus protein VP40 stimulates IL-12– and IL-18–dependent activation of human natural killer cells

inferred← citeshttps://doi.org/10.1186/1743-422x-9-111openalex-snapshot

Prediction and identification of mouse cytotoxic T lymphocyte epitopes in Ebola virus glycoproteins

inferred← citeshttps://doi.org/10.1186/1743-422x-9-32openalex-snapshot

Induction of ebolavirus cross-species immunity using retrovirus-like particles bearing the Ebola virus glycoprotein lacking the mucin-like domain

inferred← citeshttps://doi.org/10.1186/s12014-016-9119-8openalex-snapshot

Development of a liquid chromatography high resolution mass spectrometry method for the quantitation of viral envelope glycoprotein in Ebola virus-like particle vaccine preparations

inferred← citeshttps://doi.org/10.1186/s12865-015-0126-8openalex-snapshot

In silico prediction of Ebola Zaire GP1,2 immuno-dominant epitopes for the Balb/c mouse

inferred← citeshttps://doi.org/10.1186/s12934-022-01929-8openalex-snapshot

Recombinant vaccines in 2022: a perspective from the cell factory

inferred← citeshttps://doi.org/10.1186/s12951-021-00806-7openalex-snapshot

Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers

inferred← citeshttps://doi.org/10.1186/s12967-015-0496-yopenalex-snapshot

Hegemonic structure of basic, clinical and patented knowledge on Ebola research: a US army reductionist initiative

inferred← citeshttps://doi.org/10.1186/s12967-015-0593-yopenalex-snapshot

A thermostable, chromatographically purified Ebola nano-VLP vaccine

inferred← citeshttps://doi.org/10.1201/b11523openalex-snapshot

Biodefense Research Methodology and Animal Models

inferred← citeshttps://doi.org/10.1201/b11523-15openalex-snapshot

Animal Models for Viral Hemorrhagic Fevers

inferred← citeshttps://doi.org/10.13345/j.cjb.180074openalex-snapshot

[A novel carbon nanoparticle probe-based ultrasensitive lateral flow assay for rapid detection of Ebola virus].

inferred← citeshttps://doi.org/10.1371/journal.pntd.0009566openalex-snapshot

Zoonotic risk factors associated with seroprevalence of Ebola virus GP antibodies in the absence of diagnosed Ebola virus disease in the Democratic Republic of Congo

inferred← citeshttps://doi.org/10.1371/journal.pone.0029030openalex-snapshot

Consequences of Non-Intervention for Infectious Disease in African Great Apes

inferred← citeshttps://doi.org/10.1371/journal.pone.0079575openalex-snapshot

Canine Parvovirus VP2 Protein Expressed in Silkworm Pupae Self-Assembles into Virus-Like Particles with High Immunogenicity

inferred← citeshttps://doi.org/10.1371/journal.pone.0089735openalex-snapshot

Toll-Like Receptor Agonist Augments Virus-Like Particle-Mediated Protection from Ebola Virus with Transient Immune Activation

inferred← citeshttps://doi.org/10.1371/journal.pone.0118434openalex-snapshot

Mechanisms of Immunity in Post-Exposure Vaccination against Ebola Virus Infection

inferred← citeshttps://doi.org/10.1371/journal.pone.0118881openalex-snapshot

Homologous and Heterologous Protection of Nonhuman Primates by Ebola and Sudan Virus-Like Particles

inferred← citeshttps://doi.org/10.1371/journal.pone.0162446openalex-snapshot

Ebolavirus Glycoprotein Fc Fusion Protein Protects Guinea Pigs against Lethal Challenge

inferred← citeshttps://doi.org/10.1371/journal.ppat.0020001openalex-snapshot

Gene-Specific Countermeasures against Ebola Virus Based on Antisense Phosphorodiamidate Morpholino Oligomers

inferred← citeshttps://doi.org/10.1371/journal.ppat.0020073openalex-snapshot

Molecular Determinants of Ebola Virus Virulence in Mice

inferred← citeshttps://doi.org/10.1371/journal.ppat.1005487openalex-snapshot

The Myeloid LSECtin Is a DAP12-Coupled Receptor That Is Crucial for Inflammatory Response Induced by Ebola Virus Glycoprotein

inferred← citeshttps://doi.org/10.1371/journal.ppat.1006397openalex-snapshot

Ebola virus glycoprotein directly triggers T lymphocyte death despite of the lack of infection

inferred← citeshttps://doi.org/10.1371/journal.ppat.1010039openalex-snapshot

Species-specific quantification of circulating ebolavirus burden using VP40-derived peptide variants

inferred← citeshttps://doi.org/10.1517/14712598.2012.685152openalex-snapshot

Current ebola vaccines

inferred← citeshttps://doi.org/10.1586/14760584.2014.885841openalex-snapshot

Ebola virus vaccines: an overview of current approaches

inferred← citeshttps://doi.org/10.1586/14760584.4.3.429openalex-snapshot

Filovirus-like particles as vaccines and discovery tools

inferred← citeshttps://doi.org/10.1586/14760584.7.3.333openalex-snapshot

Protection against filovirus infection: virus-like particle vaccines

inferred← citeshttps://doi.org/10.1586/erv.10.152openalex-snapshot

Progress in filovirus vaccine development: evaluating the potential for clinical use

inferred← citeshttps://doi.org/10.1590/1678-4324-2025240942openalex-snapshot

VLP (Virus-Like Particles) Vaccines - Current Knowledge and Future Directions

inferred← citeshttps://doi.org/10.17169/refubium-5817openalex-snapshot

Filoviruses attach to a common cell-surface molecule via distinct and strongly immunogenic receptor-binding regions, and modulate cell entry through Δ-peptides

showing the first 200 of 237

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.